Author:
Raza Azra,Mehdi Murtaza,Mumtaz Muhammad,Ali Fahad,Lascher Steven,Galili Naomi
Reference14 articles.
1. Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the Cancer and Leukemia Group B;Silverman;J Clin Oncol,2002
2. Fenaux P,Mufti GJ,Santini V, et al. Azacitidine (AZA) treatment prolongs overall survival (OS) in higher-risk MDS patients compared with conventional care regimens (CCR): results of the AZA-001 phase III study. Program and abstracts of the 49th Annual Meeting of American Society of Hematology, Atlanta, Georgia, December 8-11, 2007. Abstract 817.
3. 5-Azacytidine in acute leukemia;Saiki;Cancer,1978
4. Low dose 5-azacytidine is ineffective for remission induction in patients with acute myeloid leukemia;Lee;Leukemia,1990
5. Drug insight: thalidomide as a treatment for multiple myeloma;Kumar;Nat Clin Pract Oncol,2005
Cited by
64 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献